EPISODE · Nov 24, 2025 · 17 MIN
Episode 1 - Evolution of Antibody Drug Conjugates
from Bridges - Advances in Cancer Therapeutics · host ADC Therapeutics
Join us for a high-level look at antibody drug conjugates (ADCs) in lymphoma treatment. Dr. Weiyun Ai provides a detailed overview of ADCs—a pioneering method that can change how lymphoma is treated. Learn how they target cancer, overcome obstacles, and pave the way for developing new combination therapies.Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & BloodGuest: Dr. Weiyun Ai, Professor of Medicine, University of California, San Francisco
NOW PLAYING
Episode 1 - Evolution of Antibody Drug Conjugates
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m